PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Knowledge and worry following review of standard vs patient-centered pathology reports

JAMA

2025-01-02
(Press-News.org)

About The Study: Most study participants could not extract basic information—including whether they have cancer—from standard prostate cancer pathology reports but were able to understand this diagnostic information from the patient-centered pathology reports (PCPRs). Also, they discriminated between risk levels (i.e., lower levels of perceived worry in the low-risk condition) with PCPRs compared with standard reports. Hospital systems should consider including PCPRs with standard pathology reports to improve patient understanding. 

Corresponding Author: To contact the corresponding author, Cathryn J. Lapedis, MD, MPH, MS, email cathrynb@med.umich.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2024.25461)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.25461?guestAccessKey=750b4a2a-5207-46ca-b9c1-a6e27b0df59b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010225

 

END



ELSE PRESS RELEASES FROM THIS DATE:

Cardiovascular disease and breast cancer stage at diagnosis

2025-01-02
About The Study: This case-control study found that individuals with more advanced breast cancer at diagnosis were more likely to have prevalent cardiovascular disease. This finding may be specific to hormone receptor–positive and ERBB2-negative (formerly HER2) disease. Future studies are needed to confirm these findings and investigate interventions to improve patient outcomes, including personalized cancer screening. Corresponding Author: To contact the corresponding author, Kevin T. Nead, MD, MPhil, email ktnead@mdanderson.org. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2024.52890) Editor’s ...

Herpes virus might drive Alzheimer's pathology, study suggests

Herpes virus might drive Alzheimers pathology, study suggests
2025-01-02
PITTSBURGH, Jan. 2, 2025 – University of Pittsburgh researchers uncovered a surprising link between Alzheimer’s disease and herpes simplex virus-1 (HSV-1), suggesting that viral infections may play a role in the disease. The study results are published today in Cell Reports. The study also revealed how tau protein, often viewed as harmful in Alzheimer’s, might initially protect the brain from the virus but contribute to brain damage later. These findings could lead to new treatments targeting infections and the brain’s immune response. “Our study challenges ...

Patients with heart disease may be at increased risk for advanced breast cancer

Patients with heart disease may be at increased risk for advanced breast cancer
2025-01-02
HOUSTON ― Cardiovascular disease (CVD) and cancer are the two leading causes of death in the U.S. According to researchers from The University of Texas MD Anderson Cancer Center, patients diagnosed with late-stage or metastatic breast cancer have a statistically significant increased risk of pre-diagnosis CVD compared to those with early-stage cancer at diagnosis. The study, published today in JAMA Network Open, found those with advanced breast cancer at diagnosis were 10% more likely to have had pre-existing ...

Chinese Medical Journal study reveals potential use of artificial intelligence (AI) in finding new glaucoma drugs

Chinese Medical Journal study reveals potential use of artificial intelligence (AI) in finding new glaucoma drugs
2025-01-02
Glaucoma is a progressive eye disorder characterized by fluid buildup inside the eye, causing ocular hypertension. By 2040, it is estimated that 111.8 million people worldwide will be affected by glaucoma, potentially leading to blindness if left untreated. Currently, there are treatments available to manage ocular hypertension, but a cure for glaucoma remains elusive. Retinal ganglion cells (RGCs) are crucial for transmitting visual signals from the eyes to the brain, and their degeneration leads to optic nerve damage, which is a hallmark of glaucoma.  In recent years, scientists ...

Genomic analysis of modern maize inbred lines reveals diversity and selective breeding effects

Genomic analysis of modern maize inbred lines reveals diversity and selective breeding effects
2025-01-02
Maize is a globally cultivated staple crop and one of the most successful examples of heterosis utilization in food production. The development of elite inbred lines is critical for breeding hybrid varieties and achieving sustained yield improvements. However, efficient breeding of inbred lines faces significant challenges, including the broad origins of germplasm resources, complex and diverse genetic structures, and low accuracy in phenotypic prediction. Advances in modern genomics and artificial intelligence technologies ...

Research alert: Enzyme promoting tumor growth and spread in pancreatic cancer identified

2025-01-02
Pancreatic cancer kills 50,000 people each year, according to the National Cancer Institute, and there are few effective treatment options for the disease. In a new study, researchers at University of California San Diego School of Medicine have discovered that an enzyme called MICAL2 promotes tumor growth and spread in pancreatic ductal adenocarcinomas (PDAC), the most common form of pancreatic cancer. The study will be published on January 2, 2025 in Cancer Research, a journal of the American Association for Cancer Research. Normally, MICAL2 plays an important role in cell migration and morphology. But when the researchers measured ...

NIH officials assess threat of H5N1

NIH officials assess threat of H5N1
2025-01-02
WHAT: Highly pathogenic H5N1 avian influenza A virus (HPAI H5N1) remains a low risk to the general public, and public health experts in the United States believe that available treatments and vaccines, as well as those in development, are sufficient to prevent severe disease. However, the National Institutes of Health (NIH) and its federal partners remain focused on monitoring the virus and evaluating changes, according to leading officials at the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH.  In a commentary published in the New England Journal of Medicine, NIAID Director Jeanne M. Marrazzo, M.D., M.P.H., and Michael G. Ison, M.D., M.S., chief ...

Study finds physical activity reduces chronic disease risk

Study finds physical activity reduces chronic disease risk
2025-01-02
University of Iowa researchers are recommending all patients be surveyed about their physical activity levels, after a new study underscores the link between physical activity and chronic disease. The study, led by Lucas Carr, associate professor in the Department of Health and Human Physiology, examined responses from more than 7,000 patients at University of Iowa Health Care Medical Center who noted their level of physical activity in a questionnaire.  From patients’ answers to the questionnaire, the researchers found that those who reported the highest level of physical activity — meaning they exercised moderately ...

Based on AI-powered De novo Generation, Insilico Medicine nominates ISM1745 as preclinical candidate targeting PRMT5

Based on AI-powered De novo Generation, Insilico Medicine nominates ISM1745 as preclinical candidate targeting PRMT5
2025-01-02
Since 2021, Insilico Medicine has successfully nominated 22 preclinical candidates (PCCs) with the help of its proprietary Pharma.AI platform, among which 5 were nominated just the year of 2024. The novel scaffold of ISM1745 is based on de novo generation results of Insilico’s Chemistry42, the generative AI platform combining more than 40 generative models. With in vivo anti-tumor activity validated in multiple cancer models, the candidate compound showed robust in vivo efficacy as monotherapy as well as combination potential with chemotherapies, targeted agents including MAT2A inhibitor, and immunotherapies. CAMBRIDGE, ...

A “ticking time bomb” for liver cancer

A “ticking time bomb” for liver cancer
2025-01-02
Scientists at University of California San Diego School of Medicine have shed new light on the development of liver cancer, the sixth most frequently diagnosed cancer and fourth leading cause of cancer deaths worldwide. The study, published in Nature, reveals a complex interplay between cellular metabolism and DNA damage that drives the progression of fatty liver disease to cancer. The findings suggest new paths forward for preventing and treating liver cancer and have significant implications on our understanding of cancer’s origin and the effects of diet on our DNA. The incidence of the most common form of liver cancer, hepatocellular carcinoma (HCC), has grown by 25-30% in the past ...

LAST 30 PRESS RELEASES:

How can visual artists protect their work from AI crawlers? It’s complicated

Progress toward a population screening test for COPD

University of Bath leads world’s largest growth and maturation study in elite football to support early and late developers

New technique uses focused sound waves and holograms to control brain circuits

New study reveals simple peptides can mimic nature’s protein protection strategy

Just rise: Study finds frequent standing may boost heart health after menopause

Trauma psychology transformed: Professor Philip Hyland reshapes global understanding of PTSD diagnosis

You’re better at spotting malware than you think

Baby star sets off explosion, gets caught in blast

For Mexican American millennials, personal success includes providing for parents

How Aussie skinks outsmart lethal snake venom

PeroCycle appoints new CEO and opens £4M seed round to decarbonise steelmaking

Shining light on how brain signals control stress

Small electric shocks to ear can boost self-compassion from meditation training

Metabolism may unlock the secret to a deeper understanding of neurodegeneration

Resource-poor neighborhood conditions may increase gestational diabetes risk

Turning down the dial on inflammation to protect against lupus nephritis

Mailing at-home test kits most effective in getting people ages 45 to 49 to screen for colorectal cancer, UCLA study finds

It’s not just how many – it’s when: Global study reveals people judge a potential partner’s sexual history by timing, not total number

Fast food, including cheeseburgers and fried chicken, shouldn’t be sold in hospitals, say most Americans in new poll

UofL research shows combined exposure to alcohol and “forever chemicals” increases liver damage

Brown University neuroscientists help identify a biomarker for Alzheimer’s disease progression

Imperfect underground processes help filter wastewater in Florida Keys

Both flexibility and persistence make some birds successful in human-made environments

Biodiversity matters in every forest, but even more in wetter ones

Phase 3 study supports use of canagliflozin for type 2 diabetes in children and adolescents

Small protein, big impact: Insights into how bacteria stabilize a key outer membrane complex

Study finds gaps in evidence for air cleaning technologies designed to prevent respiratory infections

Study shows major health insurance gap for some adopted children

Midwestern butterfly count: Big data yields bad news and clues

[Press-News.org] Knowledge and worry following review of standard vs patient-centered pathology reports
JAMA